Announcements
Sidley Is Representing HeadFirst Global on Its Recommended Offer to Acquire AIM-Listed Impellam Group For Approximately £483.2 Million
December 14, 2023
Sidley is representing HeadFirst Global, the HR services platform, on a recommended offer by a newly formed affiliate to acquire Impellam Group plc, an AIM-listed leading STEM workforce and recruitment group in the UK. The offer is subject to the UK Takeover Code.
Subject to regulatory approval, the deal values the entire issued share capital of Impellam at approximately £483.2 million and is expected to create an enlarged recruitment group for data, tech, and engineering talent, with a strong presence across continental Europe, the UK, and the U.S.
The team was led by James Wood and Ed Perry from Sidley’s M&A and Private Equity team and James Crooks and Chloe Smith from Sidley’s Global Finance group.
Subject to regulatory approval, the deal values the entire issued share capital of Impellam at approximately £483.2 million and is expected to create an enlarged recruitment group for data, tech, and engineering talent, with a strong presence across continental Europe, the UK, and the U.S.
The team was led by James Wood and Ed Perry from Sidley’s M&A and Private Equity team and James Crooks and Chloe Smith from Sidley’s Global Finance group.
Contacts
*Admitted to practice in Scotland. Registered foreign lawyer in England and Wales.

*Only admitted to practice in Scotland. Not admitted to practice in England and Wales.
Offices
Capabilities
Suggested News & Insights
Sidley Represents NextCure in Merger With Avere Therapeutics and Concurrent US$320 Million Private PlacementJuly 17, 2026Sidley Finishes H1 2026 Among Top Three US$1B+ Dealmakers in TexasJuly 16, 2026European Commission Signals Targeted Procedural Simplification of the Foreign Subsidies Regulation – Without Weakening EnforcementJuly 16, 2026Inspection Rights, Internal Affairs, and Personal Jurisdiction: Orchid Global’s Procedural LessonJuly 15, 2026Sidley Advises EMZ Partners on Its Significant Minority Investment in Steinbach & VollmannJuly 13, 2026Sidley Represents Sino Biopharm in an Exclusive License Agreement With AstraZenecaJuly 13, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory


